Neumora halted one trial of its depression drug navacaprant and paused a pair of late-stage studies as it tries to learn from ...

A new study has found that people taking antidepressants are more likely to gain weight over time, with continuous use ...

Psilocybin-assisted psychotherapy significantly improved a range of psychiatric symptoms among people with cancer, according ...

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...

Groundbreaking research shows psilocybin therapy equals traditional antidepressants in treating depression with potential ...

Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...